Takeda Pharmaceutical Co Ltd
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 4502-T would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2000) — listing | $74,041 1.9× | $108,177 1.9× |
| Year 6 (2005) | $56,175 1.8× | $83,111 1.8× |
| Year 11 (2010) | $41,451 1.7× | $61,596 1.7× |
| Year 16 (2015) | $25,008 1.5× | $37,088 1.5× |
| Year 21 (2020) | $13,804 1.5× | $20,683 1.5× |
| Year 26 (2025) | $2,341 1.2× | $3,535 1.2× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 4502
For illustration only — not investment advice. Past performance is not indicative of future results.